Cargando…

Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™

Aplidin™ (APL) is a new antitumoral drug from marine origin currently in phase II clinical trials against a wide multiplicity of cancers. As resistance may be, as with other drugs, an important obstacle to the APL therapeutic efficacy, we have established an acquired resistance cellular model by con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Losada, A, López-Oliva, J M, Sánchez-Puelles, J M, García-Fernández, L F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409906/ https://www.ncbi.nlm.nih.gov/pubmed/15365569 http://dx.doi.org/10.1038/sj.bjc.6602166

Ejemplares similares

Effect of Aplidin in acute lymphoblastic leukaemia cells
por: Erba, E, et al.
Publicado: (2003)

Antiangiogenic activity of aplidine, a new agent of marine origin
por: Taraboletti, G, et al.
Publicado: (2004)

Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine
por: Erba, E, et al.
Publicado: (2002)

Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma
por: Caers, J, et al.
Publicado: (2008)

Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
por: Salawu, Abdulazeez, et al.
Publicado: (2016)

No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan
por: Calvet, L, et al.
Publicado: (2004)

Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity
por: Jones, D J L, et al.
Publicado: (2004)

Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein
por: Scheffer, G L, et al.
Publicado: (2002)

Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines
por: Chauhan, S S, et al.
Publicado: (2003)

Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines
por: van Geelen, C M M, et al.
Publicado: (2003)

Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines
por: Bergman, A M, et al.
Publicado: (2003)

Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line
por: Barshishat, M, et al.
Publicado: (2002)

Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation
por: Boonstra, R, et al.
Publicado: (2004)

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
por: de Plater, L, et al.
Publicado: (2010)

Characterisation of molecular events following cisplatin treatment of two curable ovarian cancer models: contrasting role for p53 induction and apoptosis in vivo
por: Clarke, P A, et al.
Publicado: (2004)

Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin
por: Meczes, E L, et al.
Publicado: (2002)

Mechanistic studies on δ-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line
por: Correa García, S, et al.
Publicado: (2003)

Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice
por: Coelho, M, et al.
Publicado: (2004)

Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma
por: Schöffski, Patrick, et al.
Publicado: (2009)

Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines
por: Okuno, S, et al.
Publicado: (2003)

Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a(1)H NMR study
por: Ferretti, A, et al.
Publicado: (2002)

AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2
por: Fahy, B N, et al.
Publicado: (2003)

The Aplidin analogs PM01215 and PM02781 inhibit angiogenesis in vitro and in vivo
por: Borjan, Bojana, et al.
Publicado: (2015)

Sulindac targets nuclear β-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines
por: Boon, E M J, et al.
Publicado: (2004)

A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin
por: Tang, H-J, et al.
Publicado: (2004)

Antisense inhibition of methylenetetrahydrofolate reductase reduces survival of methionine-dependent tumour lines
por: Sekhon, J, et al.
Publicado: (2002)

An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines
por: Sangar, V K, et al.
Publicado: (2004)

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine
por: Overman, M J, et al.
Publicado: (2010)

Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR–β1 integrin complex in colon cancer cells
por: Ahmed, N, et al.
Publicado: (2003)

Staurosporine-induced apoptosis and hydrogen peroxide-induced necrosis in two human breast cell lines
por: McKeague, A L, et al.
Publicado: (2003)

Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines
por: Fustier, P, et al.
Publicado: (2003)

(213)Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model
por: Li, Y, et al.
Publicado: (2002)

Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis
por: Yokoyama, H, et al.
Publicado: (2006)

Gefitinib (‘Iressa’, ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2
por: Nutt, J E, et al.
Publicado: (2004)

Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs
por: Li, S, et al.
Publicado: (2004)

Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence
por: Watson, S A, et al.
Publicado: (2002)

Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation
por: Schweyer, S, et al.
Publicado: (2004)

α-Tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-κB activation
por: Dalen, H, et al.
Publicado: (2003)

Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1
por: Eberle, J, et al.
Publicado: (2002)

Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines
por: Liem, A A, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_tq5pvovc0fnfq0veud3v65c64j